AstraZeneca Acquires Neogene Therapeutics for $320 Million November 30, 2022 AutoBot News 0 AstraZeneca inked a deal worth up to $320 million to purchase Neogene Therapeutics, a biotech start-up focused on T-cell receptor therapies.